Sprifermin shows promise in knee osteoarthritis by Anna Smith | Oct 9, 2019 | News | 0 There are no approved drugs at current for preventing or slowing disease progression. Read More
Alkermes boosted by trial success for antidepressant by Selina McKee | Oct 21, 2016 | News | 0 Shares in Ireland-headquartered Alkermes shot up nearly 50 percent after its experimental depression drug hit targets in a pivotal late-stage trial. Read More